Cargando…
Adenoviral-Vectored Centralized Consensus Hemagglutinin Vaccine Provides Broad Protection against H2 Influenza a Virus
Several influenza pandemics have occurred in the past century, one of which emerged in 1957 from a zoonotic transmission of H2N2 from an avian reservoir into humans. This pandemic caused 2–4 million deaths and circulated until 1968. Since the disappearance of H2N2 from human populations, there has b...
Autores principales: | Petro-Turnquist, Erika M., Bullard, Brianna L., Pekarek, Matthew J., Weaver, Eric A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229510/ https://www.ncbi.nlm.nih.gov/pubmed/35746534 http://dx.doi.org/10.3390/vaccines10060926 |
Ejemplares similares
-
Adenoviral-vectored epigraph vaccine elicits robust, durable, and protective immunity against H3 influenza A virus in swine
por: Petro-Turnquist, Erika, et al.
Publicado: (2023) -
An epitope-optimized human H3N2 influenza vaccine induces broadly protective immunity in mice and ferrets
por: Bullard, Brianna L., et al.
Publicado: (2022) -
Efficacy of an Adenoviral Vectored Multivalent Centralized Influenza Vaccine
por: Lingel, Amy, et al.
Publicado: (2017) -
Influenza H1 Mosaic Hemagglutinin Vaccine Induces Broad Immunity and Protection in Mice
por: Corder, Brigette N., et al.
Publicado: (2019) -
Strategies Targeting Hemagglutinin as a Universal Influenza Vaccine
por: Bullard, Brianna L., et al.
Publicado: (2021)